Honestly, if you want to talk about relative risk, I'm surprised you don't have that information already - especially given the implications your making. Of course there are always other conditions and diseases, this absolutely is reflected in the available data. Feel free to bring up specifics once you've retrieved and analysed them at your leasure. Happy to discuss them once you have.
> Of course there are always other conditions and diseases, this absolutely is reflected in the available data. Feel free to bring up specifics [..]
Covid is simply too new for any of us to have reliable long-term data. Even the UK's ONS said so in the Spring[0]:
"More deaths were registered in young people aged 15 to 29 years in England in 2021 than the average number registered in 2015 to 2019; however, there was no excess in 2021 for deaths from circulatory diseases.
We do not yet have a complete picture of how the coronavirus pandemic has affected deaths in young people, because it takes a long time to investigate deaths from external causes; we will continue to monitor the safety of vaccines and the changes in excess deaths.
Early indications show deaths in 2020 increased for some causes, particularly suicides in young females and accidental poisonings (mostly drug poisonings) in young males"
So let's put Covid to one side and talk about seasonal flu, since that's been with us for long enough.
The US and Canada were (at least relatively recently) the only places that recommend everyone over six months to get the (seasonal) flu vaccine.[1]
"Apparently, not a single country in Europe asks the general population to seek that same kind of protection, according to Robb Butler, the World Health Organization technical officer in vaccine preventable diseases and immunizations in the organization's Europe office in the Netherlands.
That's because global health experts say the data aren't there yet to support this kind of blanket vaccination policy, nor is there enough money"
The USA is "the land of the medicated" according to a NBC article[1] and "What the drug companies are doing now is promoting drugs for long-term use to essentially healthy people. Why? Because it’s the biggest market."[2]
YMMV, but $BigPharma's shareholders would definitely prefer you to take more medicine, and not ask too many questions.
So, if you want to examine the data we do have about risks from COVID-19 in the setting of comparative risk, including other diseases, then I'm happy to do so. However, I do not wish to speculate about COVID-19 by changing the topic of discussion to influenza, excluding COVID-19, in this context, as though it were comparable. COVID-19 is not the flu. Speculating about data is not what we're discussing. If we don't have the long term data, we don't have the data. We do have preliminary data for COVID-19, so if you want to speculate about that and how it might develop - that'd be much more relevant.
